C4 Therapeutics
CCCC
CCCC
118 hedge funds and large institutions have $366M invested in C4 Therapeutics in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 26
4.07% more ownership
Funds ownership: 88.49% → 92.56% (+4.1%)
3% more funds holding
Funds holding: 115 → 118 (+3)
Holders
118
Holding in Top 10
2
Calls
$4.89M
Puts
$941K
Top Buyers
| 1 | +$16.3M | |
| 2 | +$14.5M | |
| 3 | +$6.77M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.26M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.73M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$5.9M | |
| 3 | -$2.78M | |
| 4 |
Two Sigma Investments
New York
|
-$2.73M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.61M |